Black Swift Group LLC Boosts Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Black Swift Group LLC boosted its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 34.1% in the third quarter, Holdings Channel.com reports. The fund owned 106,500 shares of the construction company’s stock after buying an additional 27,100 shares during the quarter. Black Swift Group LLC’s holdings in Aspen Aerogels were worth $2,949,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of ASPN. Oppenheimer & Co. Inc. purchased a new stake in shares of Aspen Aerogels in the 1st quarter valued at about $388,000. Dakota Wealth Management acquired a new position in Aspen Aerogels during the third quarter worth approximately $986,000. Rice Hall James & Associates LLC lifted its stake in Aspen Aerogels by 19.9% in the third quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock valued at $14,817,000 after buying an additional 88,711 shares during the last quarter. Comerica Bank acquired a new stake in shares of Aspen Aerogels in the first quarter valued at approximately $1,992,000. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Aspen Aerogels by 66.7% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after acquiring an additional 32,243 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts recently commented on ASPN shares. Roth Mkm reduced their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Barclays dropped their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Performance

ASPN opened at $15.52 on Thursday. Aspen Aerogels, Inc. has a 1-year low of $9.89 and a 1-year high of $33.15. The stock has a market cap of $1.27 billion, a P/E ratio of 1,553.55 and a beta of 2.21. The stock’s 50 day simple moving average is $22.44 and its 200 day simple moving average is $24.67. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.